The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 1995;332(22):1527.

Review Article
Medical Progress
PreviousPrevious
Volume 332:791-803 March 23, 1995 Number 12
NextNext

Cushing's Syndrome
David N. Orth, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
-PubMed Citation
Harvey W. Cushing's 1932 description1 of the syndrome that results from long-term exposure to glucocorticoids has not been improved upon, but our understanding of its pathophysiologic features and our ability to diagnose and treat the disorder have increased dramatically.

Normal Hypothalamic–Pituitary–Adrenal Physiology

Corticotropin-releasing hormone (CRH)2 is synthesized in the hypothalamus and carried to the anterior pituitary in portal blood (Figure 1). CRH, whose secretion is regulated by a variety of neurotransmitters,3 is the most potent regulator of corticotropin secretion. Arginine vasopressin and other hypothalamic agents also stimulate corticotropin secretion.4,5


View larger version (36K):
[in this window]
[in a new window]
 
Figure 1. Physiologic and Pathophysiologic Features of the Hypothalamic–Pituitary–Adrenal Axis in Normal Subjects and . . . [Full Text of this Article]

 
Pathophysiologic Features of Cushing's Syndrome

Corticotropin-Dependent Cushing's Syndrome

            Cushing's Disease

            Ectopic Corticotropin Syndrome

            Ectopic CRH Syndrome

            Pseudo–Cushing's Syndrome

Corticotropin-Independent Cushing's Syndrome

            Adrenocortical Tumors

            Bilateral Micronodular Hyperplasia

            Bilateral Macronodular Hyperplasia

Diagnosis

Diagnosis of Cushing's Syndrome

            Clinical Diagnosis

            Laboratory Confirmation

Distinguishing between Corticotropin-Dependent and Corticotropin-Independent Cushing's Syndrome

Determining the Source of Excess Corticotropin Secretion

            High-Dose Dexamethasone Suppression Tests

            Metyrapone Stimulation Test

            Petrosal Venous Sinus Catheterization

Determining the Source of Corticotropin in Patients Whose Hypersecretion Cannot Be Suppressed with Dexamethasone

Imaging Procedures

Role of the CRH Stimulation Test

Treatment

Cushing's Disease

Ectopic Corticotropin and CRH Syndromes

Primary Adrenal Disease

Summary


Source Information

From the Division of Endocrinology, Department of Medicine, Vanderbilt Medical Center North, Nashville.

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.